Find the Perfect Plan for Your Investment Journey
S
Latest price
52 Week Range
€0.47 - €4.39
Next Earnings Date
May 23 2025 (Estimate)
Next Earnings Date
May 23 2025 (Est.)
Latest price
Market Cap | €54.45M |
EV | €90.76M |
Shares Outstanding | 52.87M |
Beta | -0.02 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €3.97 |
P/E 2025E | - |
P/Revenue 2025E | 88.17x |
Revenue | -34.10% |
EPS | 2.10% |
Operating Cash Flow | 5.00% |
Free Cash Flow | -13.50% |
Revenue | 3546.80% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 80.00% |
Net Profit Margin 2025E | -2833.85% |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
S
Sequana Medical NV
SEQUA
Sector
Healthcare
Industry
Medical - Devices
CEO
Crosbie, Ian
Employees
48
Website
www.sequanamedical.comIPO Date
2019-02-11
Headquarters
Kortrijksesteenweg 1112, box 102, Sint-Denijs-Westrem, Gent, East Flanders, 9051, Belgium
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved